Synergy Healthcare reports ‘successful year’

Sterilisation and infection control solutions provider Synergy Healthcare has announced its preliminary results for the year ended March 2008, with the company reporting another successful financial year.

The company reported a 47.4 per cent increase in revenues to 225 million pounds, with underlying revenues excluding its acquisitions of Vernon Carus and Isotron up by 16.9 per cent.

Profit before tax rose by 47.7 per cent to 24.9 million pounds, with adjusted earnings per share up 21.4 per cent to 35.5p.

In November 2007, the company announced the start of operations at its Manchester facility under the NHS National Decontamination Programme, while its surgical division won 5.3 million pounds of new contracts outside the national programme during the year.

Richard Steeves, chief executive of Synergy Healthcare, said: “Synergy Healthcare has the benefit of an increasing exposure to the global healthcare market, which continues to grow robustly driven by positive changes in demographics and increasing wealth in the Asian regions where Synergy is expanding its presence.”

He added that the company has an order book worth over 800 million pounds with additional capacity coming on stream during the current financial year.

Last month, Synergy announced the launch of a new MRSA testing service to help hospitals in the fight against hospital bugs.